ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy

ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy

Liming Song,1– 3 Yahui Wu,1– 3 Senfeng Zhao,1– 3 Yin Liu,1– 3 Zhipu Liu,1– 3 Yunpeng Zhai,1– 3 Jiahui Cao,1– 3 Yaning Xia,4 Ruopeng Liang,1– 3 Weijie Wang,1– 3 Rongtao Zhu,1– 3 Binghua Sun,5 Yupeng Shi,4 Yuling Sun1– 3 1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospita...

Full description

Saved in:
Bibliographic Details
Main Authors: Song L, Wu Y, Zhao S, Liu Y, Liu Z, Zhai Y, Cao J, Xia Y, Liang R, Wang W, Zhu R, Sun B, Shi Y, Sun Y
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:International Journal of Nanomedicine
Subjects:
Drug delivery
Reactive oxygen species
Hypoxia
Regorafenib
Nanocarrier
Online Access:https://www.dovepress.com/ros-responsive-nanosystem-targeted-co-delivery-yc-1-and-regorafenib-to-peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items